Pharmacological Treatment of Juvenile Idiopathic Arthritis PDF Print E-mail

Release Date: May 1, 2008
Time to Complete: 1 hour
Date Credit Expires: May 2010
Credit renewed May 2009		 Medium: Internet Online
Most Recent Review: May 1, 2008


Instructions for Participation

  1. Read the information provided on this page
  2. Click "Take this course" at the bottom of the page
  3. Study the educational activity by clicking on each page in sequence
  4. Answer the CME questions
  5. At the end of the module, follow the link to the module evaluation
  6. After completing the evaluation, download the certificate


Target Audience
This activity is intended for primary care and specialty providers who care for children with juvenile idiopathic arthritis.


Learning Objectives
After completing this course, the reader should be able to:
  1. Administer and encourage appropriate adherence to medications within the context of a medical 'home'
  2. Recognize key side effects, interactions, and laboratory abnormalities with different drug classes, including appropriate follow-up and monitoring
  3. Manage routine immunizations and acute infections in patients receiving therapy
  4. Appropriately refer patients for uveitis screening.

Disclosure Declarations
Faculty

 Thomas Belhorn, MD
Associate Professor, Division of Allergy, Immunology, Rheumatology, and Infectious Disease, Department of Pediatrics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Disclosures: The author has indicated no relevant commercial relationships.

Timothy Beukelman, MD
Assistant Professor, Division of Pediatric Rheumatology, Department of Pediatrics, University of Alabama at Birmingham, Birmingham, AL, USA.
Disclosures: The author has indicated no relevant commercial relationships.

Esi Morgan DeWitt, MD, MSCE
Assistant Professor, Department of Pediatrics and Duke Clinical Research Institute, Duke University Medical Center, Durham, NC, USA.
Disclosures: The author has indicated no relevant commercial relationships.

Leonard Stein, MD
Professor, Department of Pediatrics, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Disclosures: The author is Principal Investigator of a clinical research project with Amgen Immunex.


 PEDS Core Faculty and Planners

Disclosures: The members of the PEDS Core have no relevant commercial relationships.

Sue Tolleson-Rinehart, PhD
Assistant Chair for Faculty Development, Department of Pediatrics, School of Medicine, and Co-Associate Director, Health Care and Prevention MPH Program, School of Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

Alan D. Stiles, MD
Brewer Distinguished Professor and Chair, Department of Pediatrics, University of North Carolina at Chapel Hill and Physician-in-Chief, NC Children's Hospital, Chapel Hill, NC, USA.

Sara E. Massie, MPH
Project Manager, PEDS and the UNC Center for Education and Research on Therapeutics, Department of Pediatrics, School of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

Joel C. Boggan, MPH
Fourth Year Medical Student, School of Medicine, Duke University, Durham, NC, USA.

Adam Froyum Roise, MPH
Fourth Year Medical Student, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

Thomas L. Goolsby
First Year Master's Student, Health Policy and Administration, School of Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

Jordan M. Kautz, MPH
Fourth Year Medical Student, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

Christopher Racine
Third Year Medical Student, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

Matthew D. Olson
Fourth Year Medical Student, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

Victoria Pham
Second Year Master's Student, Health Behavior and Health Education, School of Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

Mitchell D. Shores
President, Transcribo MD, Chapel Hill, NC, USA.



 
Accreditation
The School of Medicine of The University of North Carolina at Chapel Hill is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
 
Credit Designation
The School of Medicine of The University of North Carolina at Chapel Hill designates each PEDS CME course for a maximum of 1 AMA PRA Category 1 Credit™. Attendance certificates may be provided to all health professionals, but only licensed physicians (MDs or DOs) may receive certificates that reflect AMA PRA Category 1 Credit™. Other health care professionals will receive a certificate of attendance that shows that the activity was designated for AMA PRA Category 1 Credit(s)™. 
 
Disclosure Policy
In accordance with the ACCME Essentials and Standards, everyone involved in planning PEDS CME courses has disclosed any relevant financial relationships with commercial interests in the health care industry. UNC CME staff have no relevant commercial relationships. Disclosure details are available at the start of each module under Disclosure Declarations. For more information on the faculty, planners, and managers of these courses, visit Faculty & Planner Bios.
 
Commercial Support
There is no commercial support of PEDS CME modules.
 
Sponsored by
The School of Medicine of The University of North Carolina at Chapel Hill, The Department of Pediatrics
 
System Requirements
PEDS CME supports current production versions of Safari, Firefox, Mozilla, Netscape 6.1 and above, and Explorer 6.0 and above.
 
©2010 PEDS: Pediatric Education for Drug Safety